Jens Gertow

Holds a PhD in transplantation immunology from the Karolinska Institute and joined Mabtech in 2015. Works with Life Science and listens to Death Metal. Thinks cell therapy is the best thing since sliced bread.

Jens’s recommended reads

Highlighted research, February 23, 2024

Immunoassays for immunotherapy research

Explore the critical role of ELISpot and FluoroSpot assays in immunotherapy and cell and gene therapy, empowering research and development with sensitive potency assays in line with FDA guidelines.

Tutorial, August 23, 2023

Why resting cells is essential for accurate ELISpot and FluoroSpot

Learn about the importance of resting cells before your next ELISpot or FluoroSpot.

Highlighted research, October 28, 2024

Immunoassays for infectious disease research

Explore the role of immunoassays like ELISpot and FluoroSpot in infectious disease research. Discover how Mabtech's immunoassays enable researchers to study immune responses at the cellular level for diseases like TB, SARS-CoV-2, Malaria, HIV, and more.

Tutorial, November 24, 2022

Cell stimulation in ELISpot and FluoroSpot

In this feature, we’ll walk you through the optimal use of different polyclonal and antigen-specific stimuli.

Technote, November 21, 2023

Technote: Whole Blood ELISpot

Learn how our R&D team developed and optimized a new protocol for using whole blood in the ELISpot assay.

More about Jens

Job title

Chief Commercial Officer

jens.gertow@mabtech.com